3-cyano-n-(1-3-diphenyl-1h-pyrazol-5-yl)benzamide and Alzheimer-Disease

3-cyano-n-(1-3-diphenyl-1h-pyrazol-5-yl)benzamide has been researched along with Alzheimer-Disease* in 1 studies

Other Studies

1 other study(ies) available for 3-cyano-n-(1-3-diphenyl-1h-pyrazol-5-yl)benzamide and Alzheimer-Disease

ArticleYear
A positive allosteric modulator of mGluR5 promotes neuroprotective effects in mouse models of Alzheimer's disease.
    Neuropharmacology, 2019, 12-01, Volume: 160

    Alzheimer's Disease (AD) is the most prevalent neurodegenerative disorder. Despite advances in the understanding of its pathophysiology, none of the available therapies prevents disease progression. Excess glutamate plays an important role in excitotoxicity by activating ionotropic receptors. However, the mechanisms modulating neuronal cell survival/death via metabotropic glutamate receptors (mGluRs) are not completely understood. Recent data indicates that CDPPB, a positive allosteric modulator of mGluR5, has neuroprotective effects. Thus, this work aimed to investigate CDPPB treatment effects on amyloid-β (Aβ) induced pathological alterations in vitro and in vivo and in a transgenic mouse model of AD (T41 mice). Aβ induced cell death in primary cultures of hippocampal neurons, which was prevented by CDPPB. Male C57BL/6 mice underwent stereotaxic surgery for unilateral intra-hippocampal Aβ injection, which induced memory deficits, neurodegeneration, neuronal viability reduction and decrease of doublecortin-positive cells, a marker of immature neurons and neuronal proliferation. Treatment with CDPPB for 8 days reversed neurodegeneration and doublecortin-positive cells loss and recovered memory function. Fourteen months old T41 mice presented cognitive deficits, neuronal viability reduction, gliosis and Aβ accumulation. Treatment with CDPPB for 28 days increased neuronal viability (32.2% increase in NeuN

    Topics: Allosteric Regulation; Alzheimer Disease; Amyloid beta-Peptides; Animals; Benzamides; Disease Models, Animal; Hippocampus; Male; Memory; Mice; Mice, Inbred C57BL; Mice, Transgenic; Neurodegenerative Diseases; Neurons; Neuroprotective Agents; Peptide Fragments; Pyrazoles; Receptor, Metabotropic Glutamate 5

2019